FRONT MOL BIOSCI 润色咨询

Frontiers in Molecular Biosciences

出版年份:暂无数据 年文章数:2535 投稿命中率: 开通期刊会员,数据随心看

出版周期:暂无数据 自引率:暂无数据 审稿周期: 开通期刊会员,数据随心看

前往期刊查询

期刊讨论

  1. [GetPortalCommentsPageByObjectIdResponse(id=2119003, encodeId=1f3d211900309, content=审稿速度:1.0 | 投稿命中率:95.0<br>偏重的研究方向:Cancer<br>经验分享:今年安全了,刚中了一篇综述, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=40, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTLq9qicTF5QNWGwDWEGu4UJTFXWabibYowE3lXECcPLCbLiaUuk73vtAZZEZ92AaV4W4d2CicGicXByDJA/132, createdBy=ce9b2265216, createdName=CH常, createdTime=Sat Mar 11 23:51:10 CST 2023, time=2023-03-11, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=1076702, encodeId=9bc810e670206, content=审稿速度:4.0 | 投稿命中率:50.0<br>经验分享:Initial validation阶段被拒,生信+实验验证 我自己中了两篇6、7分的生信 根据最近这个杂志发表的论文和我收到的几份这个杂志邀请审稿的生信论文水平。新颖度和工作量应该是绰绰有余,然而在initial阶段被拒,认为不符合杂志出版要求。感觉很迷。 以上供参考, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=90, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=d1265488636, createdName=Chiah, createdTime=Sat Dec 04 02:41:56 CST 2021, time=2021-12-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2095710, encodeId=afd42095e10f9, content=进裙交流:312888472, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=77, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6bda8393100, createdName=ms3000000338065901, createdTime=Mon Oct 24 01:35:34 CST 2022, time=2022-10-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1239681, encodeId=ad19123968114, content=中科院预警了还能投么?会报销版面费么?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=91, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=36a02382367, createdName=123170bfm97(暂无昵称), createdTime=Fri Aug 19 10:23:37 CST 2022, time=2022-08-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1225890, encodeId=82d41225890ba, content=影响因子是多少啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=69, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=4a655416689, createdName=ms4000001314716194, createdTime=Sat Jun 11 22:25:05 CST 2022, time=2022-06-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1221463, encodeId=7b6e1221463ef, content=mark, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=107, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200806/084a1fc92a044bc49a2f018db2b60b9d/e9eb8f6f5c374213895e9be5cfdc9022.jpg, createdBy=48191511589, createdName=peach_adore, createdTime=Sat May 21 21:29:32 CST 2022, time=2022-05-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1085410, encodeId=46a01085410af, content=投稿近一个月,依旧initial validation.有遇到相同问题的吗,求指点, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=91, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=574f5417698, createdName=鸭嘴兽花, createdTime=Wed Dec 29 12:36:43 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=973575, encodeId=aae99e3575bb, content=我2021-04-28submission.然后要我上传原始数据,我五月四号上传了,然后一直在initial validation,没有消息,给编辑邮件是在6月1号,然后6月7号收到回复,进入editorial assignment,状态显示是没有找到assistant editor.有没有被拖了很久的前辈建议一下,撤稿还是不撤!等着毕业啊!, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=88, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=d2705491352, createdName=ms1000000763087424, createdTime=Mon Jun 14 22:16:48 CST 2021, time=2021-06-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1083916, encodeId=06591083916a7, content=投稿20天依旧initial validation., beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=107, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=574f5417698, createdName=鸭嘴兽花, createdTime=Fri Dec 24 14:41:04 CST 2021, time=2021-12-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1210964, encodeId=05d212109640f, content=审稿速度:12.0 | 投稿命中率:50.0<br>偏重的研究方向:基础转化;肿瘤<br>经验分享:看文章质量和发行量来看,文章质量明显高于frontiers in oncology以及frontiers in cell and developmental biology,祝好, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=246, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=a5e35180687, createdName=146f71c6m20暂无昵称, createdTime=Wed Apr 13 21:01:24 CST 2022, time=2022-04-13, status=1, ipAttribution=)]
    2023-03-11 CH常 来自北京

    审稿速度:1.0 | 投稿命中率:95.0
    偏重的研究方向:Cancer
    经验分享:今年安全了,刚中了一篇综述

    2

    展开2条回复
  2. [GetPortalCommentsPageByObjectIdResponse(id=2119003, encodeId=1f3d211900309, content=审稿速度:1.0 | 投稿命中率:95.0<br>偏重的研究方向:Cancer<br>经验分享:今年安全了,刚中了一篇综述, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=40, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTLq9qicTF5QNWGwDWEGu4UJTFXWabibYowE3lXECcPLCbLiaUuk73vtAZZEZ92AaV4W4d2CicGicXByDJA/132, createdBy=ce9b2265216, createdName=CH常, createdTime=Sat Mar 11 23:51:10 CST 2023, time=2023-03-11, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=1076702, encodeId=9bc810e670206, content=审稿速度:4.0 | 投稿命中率:50.0<br>经验分享:Initial validation阶段被拒,生信+实验验证 我自己中了两篇6、7分的生信 根据最近这个杂志发表的论文和我收到的几份这个杂志邀请审稿的生信论文水平。新颖度和工作量应该是绰绰有余,然而在initial阶段被拒,认为不符合杂志出版要求。感觉很迷。 以上供参考, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=90, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=d1265488636, createdName=Chiah, createdTime=Sat Dec 04 02:41:56 CST 2021, time=2021-12-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2095710, encodeId=afd42095e10f9, content=进裙交流:312888472, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=77, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6bda8393100, createdName=ms3000000338065901, createdTime=Mon Oct 24 01:35:34 CST 2022, time=2022-10-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1239681, encodeId=ad19123968114, content=中科院预警了还能投么?会报销版面费么?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=91, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=36a02382367, createdName=123170bfm97(暂无昵称), createdTime=Fri Aug 19 10:23:37 CST 2022, time=2022-08-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1225890, encodeId=82d41225890ba, content=影响因子是多少啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=69, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=4a655416689, createdName=ms4000001314716194, createdTime=Sat Jun 11 22:25:05 CST 2022, time=2022-06-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1221463, encodeId=7b6e1221463ef, content=mark, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=107, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200806/084a1fc92a044bc49a2f018db2b60b9d/e9eb8f6f5c374213895e9be5cfdc9022.jpg, createdBy=48191511589, createdName=peach_adore, createdTime=Sat May 21 21:29:32 CST 2022, time=2022-05-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1085410, encodeId=46a01085410af, content=投稿近一个月,依旧initial validation.有遇到相同问题的吗,求指点, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=91, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=574f5417698, createdName=鸭嘴兽花, createdTime=Wed Dec 29 12:36:43 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=973575, encodeId=aae99e3575bb, content=我2021-04-28submission.然后要我上传原始数据,我五月四号上传了,然后一直在initial validation,没有消息,给编辑邮件是在6月1号,然后6月7号收到回复,进入editorial assignment,状态显示是没有找到assistant editor.有没有被拖了很久的前辈建议一下,撤稿还是不撤!等着毕业啊!, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=88, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=d2705491352, createdName=ms1000000763087424, createdTime=Mon Jun 14 22:16:48 CST 2021, time=2021-06-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1083916, encodeId=06591083916a7, content=投稿20天依旧initial validation., beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=107, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=574f5417698, createdName=鸭嘴兽花, createdTime=Fri Dec 24 14:41:04 CST 2021, time=2021-12-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1210964, encodeId=05d212109640f, content=审稿速度:12.0 | 投稿命中率:50.0<br>偏重的研究方向:基础转化;肿瘤<br>经验分享:看文章质量和发行量来看,文章质量明显高于frontiers in oncology以及frontiers in cell and developmental biology,祝好, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=246, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=a5e35180687, createdName=146f71c6m20暂无昵称, createdTime=Wed Apr 13 21:01:24 CST 2022, time=2022-04-13, status=1, ipAttribution=)]
    2021-12-04 Chiah

    审稿速度:4.0 | 投稿命中率:50.0
    经验分享:Initial validation阶段被拒,生信+实验验证 我自己中了两篇6、7分的生信 根据最近这个杂志发表的论文和我收到的几份这个杂志邀请审稿的生信论文水平。新颖度和工作量应该是绰绰有余,然而在initial阶段被拒,认为不符合杂志出版要求。感觉很迷。 以上供参考

    3

    展开3条回复
  3. [GetPortalCommentsPageByObjectIdResponse(id=2119003, encodeId=1f3d211900309, content=审稿速度:1.0 | 投稿命中率:95.0<br>偏重的研究方向:Cancer<br>经验分享:今年安全了,刚中了一篇综述, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=40, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTLq9qicTF5QNWGwDWEGu4UJTFXWabibYowE3lXECcPLCbLiaUuk73vtAZZEZ92AaV4W4d2CicGicXByDJA/132, createdBy=ce9b2265216, createdName=CH常, createdTime=Sat Mar 11 23:51:10 CST 2023, time=2023-03-11, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=1076702, encodeId=9bc810e670206, content=审稿速度:4.0 | 投稿命中率:50.0<br>经验分享:Initial validation阶段被拒,生信+实验验证 我自己中了两篇6、7分的生信 根据最近这个杂志发表的论文和我收到的几份这个杂志邀请审稿的生信论文水平。新颖度和工作量应该是绰绰有余,然而在initial阶段被拒,认为不符合杂志出版要求。感觉很迷。 以上供参考, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=90, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=d1265488636, createdName=Chiah, createdTime=Sat Dec 04 02:41:56 CST 2021, time=2021-12-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2095710, encodeId=afd42095e10f9, content=进裙交流:312888472, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=77, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6bda8393100, createdName=ms3000000338065901, createdTime=Mon Oct 24 01:35:34 CST 2022, time=2022-10-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1239681, encodeId=ad19123968114, content=中科院预警了还能投么?会报销版面费么?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=91, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=36a02382367, createdName=123170bfm97(暂无昵称), createdTime=Fri Aug 19 10:23:37 CST 2022, time=2022-08-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1225890, encodeId=82d41225890ba, content=影响因子是多少啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=69, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=4a655416689, createdName=ms4000001314716194, createdTime=Sat Jun 11 22:25:05 CST 2022, time=2022-06-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1221463, encodeId=7b6e1221463ef, content=mark, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=107, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200806/084a1fc92a044bc49a2f018db2b60b9d/e9eb8f6f5c374213895e9be5cfdc9022.jpg, createdBy=48191511589, createdName=peach_adore, createdTime=Sat May 21 21:29:32 CST 2022, time=2022-05-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1085410, encodeId=46a01085410af, content=投稿近一个月,依旧initial validation.有遇到相同问题的吗,求指点, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=91, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=574f5417698, createdName=鸭嘴兽花, createdTime=Wed Dec 29 12:36:43 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=973575, encodeId=aae99e3575bb, content=我2021-04-28submission.然后要我上传原始数据,我五月四号上传了,然后一直在initial validation,没有消息,给编辑邮件是在6月1号,然后6月7号收到回复,进入editorial assignment,状态显示是没有找到assistant editor.有没有被拖了很久的前辈建议一下,撤稿还是不撤!等着毕业啊!, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=88, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=d2705491352, createdName=ms1000000763087424, createdTime=Mon Jun 14 22:16:48 CST 2021, time=2021-06-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1083916, encodeId=06591083916a7, content=投稿20天依旧initial validation., beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=107, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=574f5417698, createdName=鸭嘴兽花, createdTime=Fri Dec 24 14:41:04 CST 2021, time=2021-12-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1210964, encodeId=05d212109640f, content=审稿速度:12.0 | 投稿命中率:50.0<br>偏重的研究方向:基础转化;肿瘤<br>经验分享:看文章质量和发行量来看,文章质量明显高于frontiers in oncology以及frontiers in cell and developmental biology,祝好, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=246, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=a5e35180687, createdName=146f71c6m20暂无昵称, createdTime=Wed Apr 13 21:01:24 CST 2022, time=2022-04-13, status=1, ipAttribution=)]
    2022-10-24 ms3000000338065901

    进裙交流:312888472

    0

  4. [GetPortalCommentsPageByObjectIdResponse(id=2119003, encodeId=1f3d211900309, content=审稿速度:1.0 | 投稿命中率:95.0<br>偏重的研究方向:Cancer<br>经验分享:今年安全了,刚中了一篇综述, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=40, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTLq9qicTF5QNWGwDWEGu4UJTFXWabibYowE3lXECcPLCbLiaUuk73vtAZZEZ92AaV4W4d2CicGicXByDJA/132, createdBy=ce9b2265216, createdName=CH常, createdTime=Sat Mar 11 23:51:10 CST 2023, time=2023-03-11, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=1076702, encodeId=9bc810e670206, content=审稿速度:4.0 | 投稿命中率:50.0<br>经验分享:Initial validation阶段被拒,生信+实验验证 我自己中了两篇6、7分的生信 根据最近这个杂志发表的论文和我收到的几份这个杂志邀请审稿的生信论文水平。新颖度和工作量应该是绰绰有余,然而在initial阶段被拒,认为不符合杂志出版要求。感觉很迷。 以上供参考, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=90, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=d1265488636, createdName=Chiah, createdTime=Sat Dec 04 02:41:56 CST 2021, time=2021-12-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2095710, encodeId=afd42095e10f9, content=进裙交流:312888472, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=77, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6bda8393100, createdName=ms3000000338065901, createdTime=Mon Oct 24 01:35:34 CST 2022, time=2022-10-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1239681, encodeId=ad19123968114, content=中科院预警了还能投么?会报销版面费么?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=91, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=36a02382367, createdName=123170bfm97(暂无昵称), createdTime=Fri Aug 19 10:23:37 CST 2022, time=2022-08-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1225890, encodeId=82d41225890ba, content=影响因子是多少啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=69, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=4a655416689, createdName=ms4000001314716194, createdTime=Sat Jun 11 22:25:05 CST 2022, time=2022-06-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1221463, encodeId=7b6e1221463ef, content=mark, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=107, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200806/084a1fc92a044bc49a2f018db2b60b9d/e9eb8f6f5c374213895e9be5cfdc9022.jpg, createdBy=48191511589, createdName=peach_adore, createdTime=Sat May 21 21:29:32 CST 2022, time=2022-05-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1085410, encodeId=46a01085410af, content=投稿近一个月,依旧initial validation.有遇到相同问题的吗,求指点, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=91, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=574f5417698, createdName=鸭嘴兽花, createdTime=Wed Dec 29 12:36:43 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=973575, encodeId=aae99e3575bb, content=我2021-04-28submission.然后要我上传原始数据,我五月四号上传了,然后一直在initial validation,没有消息,给编辑邮件是在6月1号,然后6月7号收到回复,进入editorial assignment,状态显示是没有找到assistant editor.有没有被拖了很久的前辈建议一下,撤稿还是不撤!等着毕业啊!, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=88, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=d2705491352, createdName=ms1000000763087424, createdTime=Mon Jun 14 22:16:48 CST 2021, time=2021-06-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1083916, encodeId=06591083916a7, content=投稿20天依旧initial validation., beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=107, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=574f5417698, createdName=鸭嘴兽花, createdTime=Fri Dec 24 14:41:04 CST 2021, time=2021-12-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1210964, encodeId=05d212109640f, content=审稿速度:12.0 | 投稿命中率:50.0<br>偏重的研究方向:基础转化;肿瘤<br>经验分享:看文章质量和发行量来看,文章质量明显高于frontiers in oncology以及frontiers in cell and developmental biology,祝好, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=246, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=a5e35180687, createdName=146f71c6m20暂无昵称, createdTime=Wed Apr 13 21:01:24 CST 2022, time=2022-04-13, status=1, ipAttribution=)]
    2022-08-19 123170bfm97(暂无昵称)

    中科院预警了还能投么?会报销版面费么?

    0

  5. [GetPortalCommentsPageByObjectIdResponse(id=2119003, encodeId=1f3d211900309, content=审稿速度:1.0 | 投稿命中率:95.0<br>偏重的研究方向:Cancer<br>经验分享:今年安全了,刚中了一篇综述, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=40, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTLq9qicTF5QNWGwDWEGu4UJTFXWabibYowE3lXECcPLCbLiaUuk73vtAZZEZ92AaV4W4d2CicGicXByDJA/132, createdBy=ce9b2265216, createdName=CH常, createdTime=Sat Mar 11 23:51:10 CST 2023, time=2023-03-11, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=1076702, encodeId=9bc810e670206, content=审稿速度:4.0 | 投稿命中率:50.0<br>经验分享:Initial validation阶段被拒,生信+实验验证 我自己中了两篇6、7分的生信 根据最近这个杂志发表的论文和我收到的几份这个杂志邀请审稿的生信论文水平。新颖度和工作量应该是绰绰有余,然而在initial阶段被拒,认为不符合杂志出版要求。感觉很迷。 以上供参考, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=90, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=d1265488636, createdName=Chiah, createdTime=Sat Dec 04 02:41:56 CST 2021, time=2021-12-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2095710, encodeId=afd42095e10f9, content=进裙交流:312888472, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=77, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6bda8393100, createdName=ms3000000338065901, createdTime=Mon Oct 24 01:35:34 CST 2022, time=2022-10-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1239681, encodeId=ad19123968114, content=中科院预警了还能投么?会报销版面费么?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=91, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=36a02382367, createdName=123170bfm97(暂无昵称), createdTime=Fri Aug 19 10:23:37 CST 2022, time=2022-08-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1225890, encodeId=82d41225890ba, content=影响因子是多少啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=69, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=4a655416689, createdName=ms4000001314716194, createdTime=Sat Jun 11 22:25:05 CST 2022, time=2022-06-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1221463, encodeId=7b6e1221463ef, content=mark, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=107, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200806/084a1fc92a044bc49a2f018db2b60b9d/e9eb8f6f5c374213895e9be5cfdc9022.jpg, createdBy=48191511589, createdName=peach_adore, createdTime=Sat May 21 21:29:32 CST 2022, time=2022-05-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1085410, encodeId=46a01085410af, content=投稿近一个月,依旧initial validation.有遇到相同问题的吗,求指点, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=91, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=574f5417698, createdName=鸭嘴兽花, createdTime=Wed Dec 29 12:36:43 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=973575, encodeId=aae99e3575bb, content=我2021-04-28submission.然后要我上传原始数据,我五月四号上传了,然后一直在initial validation,没有消息,给编辑邮件是在6月1号,然后6月7号收到回复,进入editorial assignment,状态显示是没有找到assistant editor.有没有被拖了很久的前辈建议一下,撤稿还是不撤!等着毕业啊!, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=88, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=d2705491352, createdName=ms1000000763087424, createdTime=Mon Jun 14 22:16:48 CST 2021, time=2021-06-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1083916, encodeId=06591083916a7, content=投稿20天依旧initial validation., beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=107, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=574f5417698, createdName=鸭嘴兽花, createdTime=Fri Dec 24 14:41:04 CST 2021, time=2021-12-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1210964, encodeId=05d212109640f, content=审稿速度:12.0 | 投稿命中率:50.0<br>偏重的研究方向:基础转化;肿瘤<br>经验分享:看文章质量和发行量来看,文章质量明显高于frontiers in oncology以及frontiers in cell and developmental biology,祝好, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=246, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=a5e35180687, createdName=146f71c6m20暂无昵称, createdTime=Wed Apr 13 21:01:24 CST 2022, time=2022-04-13, status=1, ipAttribution=)]
    2022-06-11 ms4000001314716194

    影响因子是多少啊

    1

    展开1条回复
  6. [GetPortalCommentsPageByObjectIdResponse(id=2119003, encodeId=1f3d211900309, content=审稿速度:1.0 | 投稿命中率:95.0<br>偏重的研究方向:Cancer<br>经验分享:今年安全了,刚中了一篇综述, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=40, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTLq9qicTF5QNWGwDWEGu4UJTFXWabibYowE3lXECcPLCbLiaUuk73vtAZZEZ92AaV4W4d2CicGicXByDJA/132, createdBy=ce9b2265216, createdName=CH常, createdTime=Sat Mar 11 23:51:10 CST 2023, time=2023-03-11, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=1076702, encodeId=9bc810e670206, content=审稿速度:4.0 | 投稿命中率:50.0<br>经验分享:Initial validation阶段被拒,生信+实验验证 我自己中了两篇6、7分的生信 根据最近这个杂志发表的论文和我收到的几份这个杂志邀请审稿的生信论文水平。新颖度和工作量应该是绰绰有余,然而在initial阶段被拒,认为不符合杂志出版要求。感觉很迷。 以上供参考, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=90, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=d1265488636, createdName=Chiah, createdTime=Sat Dec 04 02:41:56 CST 2021, time=2021-12-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2095710, encodeId=afd42095e10f9, content=进裙交流:312888472, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=77, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6bda8393100, createdName=ms3000000338065901, createdTime=Mon Oct 24 01:35:34 CST 2022, time=2022-10-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1239681, encodeId=ad19123968114, content=中科院预警了还能投么?会报销版面费么?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=91, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=36a02382367, createdName=123170bfm97(暂无昵称), createdTime=Fri Aug 19 10:23:37 CST 2022, time=2022-08-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1225890, encodeId=82d41225890ba, content=影响因子是多少啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=69, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=4a655416689, createdName=ms4000001314716194, createdTime=Sat Jun 11 22:25:05 CST 2022, time=2022-06-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1221463, encodeId=7b6e1221463ef, content=mark, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=107, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200806/084a1fc92a044bc49a2f018db2b60b9d/e9eb8f6f5c374213895e9be5cfdc9022.jpg, createdBy=48191511589, createdName=peach_adore, createdTime=Sat May 21 21:29:32 CST 2022, time=2022-05-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1085410, encodeId=46a01085410af, content=投稿近一个月,依旧initial validation.有遇到相同问题的吗,求指点, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=91, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=574f5417698, createdName=鸭嘴兽花, createdTime=Wed Dec 29 12:36:43 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=973575, encodeId=aae99e3575bb, content=我2021-04-28submission.然后要我上传原始数据,我五月四号上传了,然后一直在initial validation,没有消息,给编辑邮件是在6月1号,然后6月7号收到回复,进入editorial assignment,状态显示是没有找到assistant editor.有没有被拖了很久的前辈建议一下,撤稿还是不撤!等着毕业啊!, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=88, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=d2705491352, createdName=ms1000000763087424, createdTime=Mon Jun 14 22:16:48 CST 2021, time=2021-06-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1083916, encodeId=06591083916a7, content=投稿20天依旧initial validation., beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=107, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=574f5417698, createdName=鸭嘴兽花, createdTime=Fri Dec 24 14:41:04 CST 2021, time=2021-12-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1210964, encodeId=05d212109640f, content=审稿速度:12.0 | 投稿命中率:50.0<br>偏重的研究方向:基础转化;肿瘤<br>经验分享:看文章质量和发行量来看,文章质量明显高于frontiers in oncology以及frontiers in cell and developmental biology,祝好, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=246, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=a5e35180687, createdName=146f71c6m20暂无昵称, createdTime=Wed Apr 13 21:01:24 CST 2022, time=2022-04-13, status=1, ipAttribution=)]
    2022-05-21 peach_adore

    mark

    0

  7. [GetPortalCommentsPageByObjectIdResponse(id=2119003, encodeId=1f3d211900309, content=审稿速度:1.0 | 投稿命中率:95.0<br>偏重的研究方向:Cancer<br>经验分享:今年安全了,刚中了一篇综述, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=40, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTLq9qicTF5QNWGwDWEGu4UJTFXWabibYowE3lXECcPLCbLiaUuk73vtAZZEZ92AaV4W4d2CicGicXByDJA/132, createdBy=ce9b2265216, createdName=CH常, createdTime=Sat Mar 11 23:51:10 CST 2023, time=2023-03-11, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=1076702, encodeId=9bc810e670206, content=审稿速度:4.0 | 投稿命中率:50.0<br>经验分享:Initial validation阶段被拒,生信+实验验证 我自己中了两篇6、7分的生信 根据最近这个杂志发表的论文和我收到的几份这个杂志邀请审稿的生信论文水平。新颖度和工作量应该是绰绰有余,然而在initial阶段被拒,认为不符合杂志出版要求。感觉很迷。 以上供参考, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=90, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=d1265488636, createdName=Chiah, createdTime=Sat Dec 04 02:41:56 CST 2021, time=2021-12-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2095710, encodeId=afd42095e10f9, content=进裙交流:312888472, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=77, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6bda8393100, createdName=ms3000000338065901, createdTime=Mon Oct 24 01:35:34 CST 2022, time=2022-10-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1239681, encodeId=ad19123968114, content=中科院预警了还能投么?会报销版面费么?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=91, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=36a02382367, createdName=123170bfm97(暂无昵称), createdTime=Fri Aug 19 10:23:37 CST 2022, time=2022-08-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1225890, encodeId=82d41225890ba, content=影响因子是多少啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=69, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=4a655416689, createdName=ms4000001314716194, createdTime=Sat Jun 11 22:25:05 CST 2022, time=2022-06-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1221463, encodeId=7b6e1221463ef, content=mark, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=107, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200806/084a1fc92a044bc49a2f018db2b60b9d/e9eb8f6f5c374213895e9be5cfdc9022.jpg, createdBy=48191511589, createdName=peach_adore, createdTime=Sat May 21 21:29:32 CST 2022, time=2022-05-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1085410, encodeId=46a01085410af, content=投稿近一个月,依旧initial validation.有遇到相同问题的吗,求指点, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=91, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=574f5417698, createdName=鸭嘴兽花, createdTime=Wed Dec 29 12:36:43 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=973575, encodeId=aae99e3575bb, content=我2021-04-28submission.然后要我上传原始数据,我五月四号上传了,然后一直在initial validation,没有消息,给编辑邮件是在6月1号,然后6月7号收到回复,进入editorial assignment,状态显示是没有找到assistant editor.有没有被拖了很久的前辈建议一下,撤稿还是不撤!等着毕业啊!, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=88, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=d2705491352, createdName=ms1000000763087424, createdTime=Mon Jun 14 22:16:48 CST 2021, time=2021-06-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1083916, encodeId=06591083916a7, content=投稿20天依旧initial validation., beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=107, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=574f5417698, createdName=鸭嘴兽花, createdTime=Fri Dec 24 14:41:04 CST 2021, time=2021-12-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1210964, encodeId=05d212109640f, content=审稿速度:12.0 | 投稿命中率:50.0<br>偏重的研究方向:基础转化;肿瘤<br>经验分享:看文章质量和发行量来看,文章质量明显高于frontiers in oncology以及frontiers in cell and developmental biology,祝好, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=246, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=a5e35180687, createdName=146f71c6m20暂无昵称, createdTime=Wed Apr 13 21:01:24 CST 2022, time=2022-04-13, status=1, ipAttribution=)]
    2021-12-29 鸭嘴兽花

    投稿近一个月,依旧initial validation.有遇到相同问题的吗,求指点

    3

    展开3条回复
  8. [GetPortalCommentsPageByObjectIdResponse(id=2119003, encodeId=1f3d211900309, content=审稿速度:1.0 | 投稿命中率:95.0<br>偏重的研究方向:Cancer<br>经验分享:今年安全了,刚中了一篇综述, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=40, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTLq9qicTF5QNWGwDWEGu4UJTFXWabibYowE3lXECcPLCbLiaUuk73vtAZZEZ92AaV4W4d2CicGicXByDJA/132, createdBy=ce9b2265216, createdName=CH常, createdTime=Sat Mar 11 23:51:10 CST 2023, time=2023-03-11, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=1076702, encodeId=9bc810e670206, content=审稿速度:4.0 | 投稿命中率:50.0<br>经验分享:Initial validation阶段被拒,生信+实验验证 我自己中了两篇6、7分的生信 根据最近这个杂志发表的论文和我收到的几份这个杂志邀请审稿的生信论文水平。新颖度和工作量应该是绰绰有余,然而在initial阶段被拒,认为不符合杂志出版要求。感觉很迷。 以上供参考, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=90, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=d1265488636, createdName=Chiah, createdTime=Sat Dec 04 02:41:56 CST 2021, time=2021-12-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2095710, encodeId=afd42095e10f9, content=进裙交流:312888472, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=77, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6bda8393100, createdName=ms3000000338065901, createdTime=Mon Oct 24 01:35:34 CST 2022, time=2022-10-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1239681, encodeId=ad19123968114, content=中科院预警了还能投么?会报销版面费么?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=91, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=36a02382367, createdName=123170bfm97(暂无昵称), createdTime=Fri Aug 19 10:23:37 CST 2022, time=2022-08-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1225890, encodeId=82d41225890ba, content=影响因子是多少啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=69, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=4a655416689, createdName=ms4000001314716194, createdTime=Sat Jun 11 22:25:05 CST 2022, time=2022-06-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1221463, encodeId=7b6e1221463ef, content=mark, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=107, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200806/084a1fc92a044bc49a2f018db2b60b9d/e9eb8f6f5c374213895e9be5cfdc9022.jpg, createdBy=48191511589, createdName=peach_adore, createdTime=Sat May 21 21:29:32 CST 2022, time=2022-05-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1085410, encodeId=46a01085410af, content=投稿近一个月,依旧initial validation.有遇到相同问题的吗,求指点, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=91, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=574f5417698, createdName=鸭嘴兽花, createdTime=Wed Dec 29 12:36:43 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=973575, encodeId=aae99e3575bb, content=我2021-04-28submission.然后要我上传原始数据,我五月四号上传了,然后一直在initial validation,没有消息,给编辑邮件是在6月1号,然后6月7号收到回复,进入editorial assignment,状态显示是没有找到assistant editor.有没有被拖了很久的前辈建议一下,撤稿还是不撤!等着毕业啊!, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=88, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=d2705491352, createdName=ms1000000763087424, createdTime=Mon Jun 14 22:16:48 CST 2021, time=2021-06-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1083916, encodeId=06591083916a7, content=投稿20天依旧initial validation., beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=107, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=574f5417698, createdName=鸭嘴兽花, createdTime=Fri Dec 24 14:41:04 CST 2021, time=2021-12-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1210964, encodeId=05d212109640f, content=审稿速度:12.0 | 投稿命中率:50.0<br>偏重的研究方向:基础转化;肿瘤<br>经验分享:看文章质量和发行量来看,文章质量明显高于frontiers in oncology以及frontiers in cell and developmental biology,祝好, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=246, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=a5e35180687, createdName=146f71c6m20暂无昵称, createdTime=Wed Apr 13 21:01:24 CST 2022, time=2022-04-13, status=1, ipAttribution=)]
    2021-06-14 ms1000000763087424

    我2021-04-28submission.然后要我上传原始数据,我五月四号上传了,然后一直在initial validation,没有消息,给编辑邮件是在6月1号,然后6月7号收到回复,进入editorial assignment,状态显示是没有找到assistant editor.有没有被拖了很久的前辈建议一下,撤稿还是不撤!等着毕业啊!

    3

    展开3条回复
  9. [GetPortalCommentsPageByObjectIdResponse(id=2119003, encodeId=1f3d211900309, content=审稿速度:1.0 | 投稿命中率:95.0<br>偏重的研究方向:Cancer<br>经验分享:今年安全了,刚中了一篇综述, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=40, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTLq9qicTF5QNWGwDWEGu4UJTFXWabibYowE3lXECcPLCbLiaUuk73vtAZZEZ92AaV4W4d2CicGicXByDJA/132, createdBy=ce9b2265216, createdName=CH常, createdTime=Sat Mar 11 23:51:10 CST 2023, time=2023-03-11, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=1076702, encodeId=9bc810e670206, content=审稿速度:4.0 | 投稿命中率:50.0<br>经验分享:Initial validation阶段被拒,生信+实验验证 我自己中了两篇6、7分的生信 根据最近这个杂志发表的论文和我收到的几份这个杂志邀请审稿的生信论文水平。新颖度和工作量应该是绰绰有余,然而在initial阶段被拒,认为不符合杂志出版要求。感觉很迷。 以上供参考, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=90, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=d1265488636, createdName=Chiah, createdTime=Sat Dec 04 02:41:56 CST 2021, time=2021-12-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2095710, encodeId=afd42095e10f9, content=进裙交流:312888472, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=77, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6bda8393100, createdName=ms3000000338065901, createdTime=Mon Oct 24 01:35:34 CST 2022, time=2022-10-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1239681, encodeId=ad19123968114, content=中科院预警了还能投么?会报销版面费么?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=91, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=36a02382367, createdName=123170bfm97(暂无昵称), createdTime=Fri Aug 19 10:23:37 CST 2022, time=2022-08-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1225890, encodeId=82d41225890ba, content=影响因子是多少啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=69, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=4a655416689, createdName=ms4000001314716194, createdTime=Sat Jun 11 22:25:05 CST 2022, time=2022-06-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1221463, encodeId=7b6e1221463ef, content=mark, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=107, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200806/084a1fc92a044bc49a2f018db2b60b9d/e9eb8f6f5c374213895e9be5cfdc9022.jpg, createdBy=48191511589, createdName=peach_adore, createdTime=Sat May 21 21:29:32 CST 2022, time=2022-05-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1085410, encodeId=46a01085410af, content=投稿近一个月,依旧initial validation.有遇到相同问题的吗,求指点, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=91, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=574f5417698, createdName=鸭嘴兽花, createdTime=Wed Dec 29 12:36:43 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=973575, encodeId=aae99e3575bb, content=我2021-04-28submission.然后要我上传原始数据,我五月四号上传了,然后一直在initial validation,没有消息,给编辑邮件是在6月1号,然后6月7号收到回复,进入editorial assignment,状态显示是没有找到assistant editor.有没有被拖了很久的前辈建议一下,撤稿还是不撤!等着毕业啊!, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=88, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=d2705491352, createdName=ms1000000763087424, createdTime=Mon Jun 14 22:16:48 CST 2021, time=2021-06-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1083916, encodeId=06591083916a7, content=投稿20天依旧initial validation., beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=107, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=574f5417698, createdName=鸭嘴兽花, createdTime=Fri Dec 24 14:41:04 CST 2021, time=2021-12-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1210964, encodeId=05d212109640f, content=审稿速度:12.0 | 投稿命中率:50.0<br>偏重的研究方向:基础转化;肿瘤<br>经验分享:看文章质量和发行量来看,文章质量明显高于frontiers in oncology以及frontiers in cell and developmental biology,祝好, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=246, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=a5e35180687, createdName=146f71c6m20暂无昵称, createdTime=Wed Apr 13 21:01:24 CST 2022, time=2022-04-13, status=1, ipAttribution=)]
    2021-12-24 鸭嘴兽花

    投稿20天依旧initial validation.

    2

    展开2条回复
  10. [GetPortalCommentsPageByObjectIdResponse(id=2119003, encodeId=1f3d211900309, content=审稿速度:1.0 | 投稿命中率:95.0<br>偏重的研究方向:Cancer<br>经验分享:今年安全了,刚中了一篇综述, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=40, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTLq9qicTF5QNWGwDWEGu4UJTFXWabibYowE3lXECcPLCbLiaUuk73vtAZZEZ92AaV4W4d2CicGicXByDJA/132, createdBy=ce9b2265216, createdName=CH常, createdTime=Sat Mar 11 23:51:10 CST 2023, time=2023-03-11, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=1076702, encodeId=9bc810e670206, content=审稿速度:4.0 | 投稿命中率:50.0<br>经验分享:Initial validation阶段被拒,生信+实验验证 我自己中了两篇6、7分的生信 根据最近这个杂志发表的论文和我收到的几份这个杂志邀请审稿的生信论文水平。新颖度和工作量应该是绰绰有余,然而在initial阶段被拒,认为不符合杂志出版要求。感觉很迷。 以上供参考, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=90, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=d1265488636, createdName=Chiah, createdTime=Sat Dec 04 02:41:56 CST 2021, time=2021-12-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2095710, encodeId=afd42095e10f9, content=进裙交流:312888472, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=77, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6bda8393100, createdName=ms3000000338065901, createdTime=Mon Oct 24 01:35:34 CST 2022, time=2022-10-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1239681, encodeId=ad19123968114, content=中科院预警了还能投么?会报销版面费么?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=91, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=36a02382367, createdName=123170bfm97(暂无昵称), createdTime=Fri Aug 19 10:23:37 CST 2022, time=2022-08-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1225890, encodeId=82d41225890ba, content=影响因子是多少啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=69, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=4a655416689, createdName=ms4000001314716194, createdTime=Sat Jun 11 22:25:05 CST 2022, time=2022-06-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1221463, encodeId=7b6e1221463ef, content=mark, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=107, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200806/084a1fc92a044bc49a2f018db2b60b9d/e9eb8f6f5c374213895e9be5cfdc9022.jpg, createdBy=48191511589, createdName=peach_adore, createdTime=Sat May 21 21:29:32 CST 2022, time=2022-05-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1085410, encodeId=46a01085410af, content=投稿近一个月,依旧initial validation.有遇到相同问题的吗,求指点, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=91, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=574f5417698, createdName=鸭嘴兽花, createdTime=Wed Dec 29 12:36:43 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=973575, encodeId=aae99e3575bb, content=我2021-04-28submission.然后要我上传原始数据,我五月四号上传了,然后一直在initial validation,没有消息,给编辑邮件是在6月1号,然后6月7号收到回复,进入editorial assignment,状态显示是没有找到assistant editor.有没有被拖了很久的前辈建议一下,撤稿还是不撤!等着毕业啊!, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=88, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=d2705491352, createdName=ms1000000763087424, createdTime=Mon Jun 14 22:16:48 CST 2021, time=2021-06-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1083916, encodeId=06591083916a7, content=投稿20天依旧initial validation., beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=107, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=574f5417698, createdName=鸭嘴兽花, createdTime=Fri Dec 24 14:41:04 CST 2021, time=2021-12-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1210964, encodeId=05d212109640f, content=审稿速度:12.0 | 投稿命中率:50.0<br>偏重的研究方向:基础转化;肿瘤<br>经验分享:看文章质量和发行量来看,文章质量明显高于frontiers in oncology以及frontiers in cell and developmental biology,祝好, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=246, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=a5e35180687, createdName=146f71c6m20暂无昵称, createdTime=Wed Apr 13 21:01:24 CST 2022, time=2022-04-13, status=1, ipAttribution=)]
    2022-04-13 146f71c6m20暂无昵称

    审稿速度:12.0 | 投稿命中率:50.0
    偏重的研究方向:基础转化;肿瘤
    经验分享:看文章质量和发行量来看,文章质量明显高于frontiers in oncology以及frontiers in cell and developmental biology,祝好

    0

共258条页码: 1/26页10条/页
分享您的投稿经验,提升MI经验值,获取更多积分